CSG's American Gambit and Czech Factory Bet Can't Shake the Market's Malaise
Published on 09/07/2026 at 14:11 | Editorial boerse-global.de
A curious disconnect is playing out at the Czech defence group CSG. On paper, the company has rarely looked stronger — its order pipeline is swelling, its management ranks are being reinforced with heavy hitters from the Western defence establishment, and it is pouring capital into new production capacity on both sides of the Atlantic. Yet the share price keeps sliding, leaving investors to square an increasingly bullish operational story with a market that remains stubbornly unimpressed.
The latest move came on Friday, when CSG unveiled a roughly €49.7 million investment spread over three years to expand production of military ground systems at its Tatra Defence subsidiary in Kop?ivnice. The outlay will fund 14,000 square metres of new manufacturing floor space plus associated infrastructure. It is a bet on future demand, not a response to immediate bottlenecks — the kind of capacity-building that typically takes years to feed through to the bottom line.
That announcement follows a flurry of contract wins that underscore the group's broadening geographic reach. Late last month, CSG secured orders worth more than $50 million for bridge-laying vehicles from customers across Europe, the Middle East and Southeast Asia. In mid-August, it signed deals exceeding €150 million with Poland's Huta Stalowa Wola covering several hundred chassis for tactical vehicles, alongside a €100 million ammunition components contract with Polish firm Dezamet. The Polish connection was further showcased at the MSPO defence fair in Kielce in early September, where CSG subsidiaries presented new products.
Boardroom Reinforcements With a Transatlantic Bent
The Kop?ivnice expansion and the contract momentum come as CSG bolsters its leadership with names that carry weight in the armoured-vehicles and munitions world. Jason Monahan, formerly head of GDLS-Canada at General Dynamics, has joined, as has Thomas Berge Nielsen, ex-chief executive of Rheinmetall's global business. David Jacobs brings experience from Northrop Grumman and Raytheon, while Peter Russell, a capital markets specialist, arrived from stints at J.P. Morgan, Avast and Rentokil Initial. At subsidiary level, Tom Winney — previously with KNDS, Rheinmetall and BAE Systems — and Alexander Rüstig, the former head of German ammunition maker RWS, have also come on board.
That personnel build-out coincides with a concrete push into the United States. CSG has established CSG Land Systems North America, a new Michigan-based subsidiary that will consolidate the Excalibur Army, Tatra Defence and Tatra Trucks brands in the US market. The unit is tasked with positioning CSG in self-propelled artillery systems and all-terrain military vehicles, a move that extends the group well beyond its European core.
The Numbers Tell One Story, the Ticker Another
The operational figures give some sense of why CSG is investing so aggressively. First-half 2026 revenue climbed 17.2 per cent to €3.251 billion, driven by the defence systems core. Operating EBIT rose 12.7 per cent to €784 million, with a margin of 24.1 per cent sitting inside the group's own target range. Defence Systems alone generated €2.62 billion — 80.6 per cent of group revenue — at a margin of 28.8 per cent.
While CSG's expansion plans hinge on years of capacity-building, workplace safety is one area where UK employers can't afford to wait. A free toolkit with 41 ready-to-use templates and checklists helps you document risks properly and stay compliant. Download the free Risk Assessment Toolkit
The order book has kept growing too. Backlog plus pipeline under negotiation now reaches as much as €46 billion, up from €44 billion in March. Notably, Land Systems has become the largest contributor, a sign that CSG is diversifying away from its ammunition roots. The company has reaffirmed its full-year guidance and medium-term targets, including organic growth in the mid-teens percentage range and margin expansion to 26–28 per cent.
None of that has moved the needle where it matters most. The shares closed Friday at €16.61, down 2.5 per cent on the day. Over seven trading days the stock has lost 8.4 per cent; over 30 days the decline is 8.3 per cent. That leaves the price roughly 54 per cent below its 52-week high of €36.05, reached in January. The appointment of Ben Hudson as vice-chairman about a month ago did nothing to arrest the slide — the shares have shed a further 1.3 per cent since.
What's Weighing on the Stock
The market's scepticism has multiple sources. Most prominent are the allegations published in May by short-seller Hunterbrook Media, which questioned the proportion of ammunition CSG actually manufactures in-house. The company rejected the claims, insisting its prospectuses and public disclosures accurately reflected the business. Around the same time, the Financial Times reported that CSG had approached shareholders of Franco-German defence group KNDS with a possible purchase offer — a move that, if confirmed, would raise questions about capital allocation at a moment when the group is also spending heavily on capacity.
The analyst community has yet to speak with one voice. In mid-August, Barclays struck a cautious tone, while RBC Capital Markets upgraded the stock to Neutral with a Sector Perform rating, citing a favourable ammunition market environment. Berenberg raised its forecasts following the half-year results but simultaneously cut its price target. Fitch, for its part, affirmed CSG's credit rating on Wednesday with a stable outlook, citing the group's dominant market position.
For now, the investment case hinges on a simple question: will the capacity being built today — in Kop?ivnice, in Michigan, and across the group's European plants — translate into the earnings growth the order book implies? The market appears to be waiting for proof, and until it arrives, the gap between CSG's operational trajectory and its share price seems likely to persist.
